Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy

b3cnewswireMarch 23, 2020

Tag: Vaccitech , Oxford University , cancer immunotherapy

PharmaSources Customer Service